Tick (check) box to add article to PDF "basket"
An EU-funded project is attempting to validate a prototype test designed to predict which combination therapy would best suit individual patients with colorectal cancer, the most common form of cancer in Europe. The test is expected to lengthen the life expectancy for those with this aggressive form of cancer by indicating the most effective treatment combination for individual patients.
Published: 13 August 2015
Prof. Michael Schneider is a leading authority in the field of cardiac molecular biology. In 2008, he obtained an ERC grant to identify the mechanisms governing self-renewal of cardiac progenitor cells, a population of stem cells located in the heart itself that might be exploited to play a key role in regenerating this vulnerable organ in heart disease.
Published: 10 August 2015
Eggs are so much more than yolks and whites. For pharmaceuticals and cosmetics companies, the membrane within the shell is highly prized. With an innovative new technology to separate the membrane from the mineral shell without damaging the former, EU-funded researchers are filling a gap in the market and addressing the waste problem facing companies using eggs.
Published: 6 August 2015
Why should gluten intolerance condemn people to a lifetime of limited - and often bland - food choices? By using new innovative ingredients and techniques to replicate the taste and texture of gluten, an EU-funded project has taken impressive steps to ensure that nothing is off the menu. The project's techniques are also helping Europe's smaller food manufacturers develop new products for the gluten-free market, helping them compete.
Published: 4 August 2015
By developing techniques to produce everyday foods that are both affordable and nutritious, EU-funded researchers are showing the path to a future in which everyone - including those at risk of poverty - can enjoy a healthy diet without worrying about cost. The project's techniques are being applied by small food processors - a boost to their competitiveness.
Published: 3 August 2015
Europe's smaller agri-businesses will soon be able to tell whether their products are within the EU's strict limits for pesticide residues without having to send samples to the laboratory. This is because an EU-funded project has developed a rapid, easy-to-use portable biosensor that offers testing up to 10 times cheaper than conventional means.
Published: 30 July 2015
Breast cancer is a leading cause of death for women, despite screening programmes cutting mortality rates. EU-funded researchers have developed new tools for personalised screening programmes to improve detection and prognosis - several of which are ready for use.
Published: 29 July 2015
For the first time ever, two ERC grantees, Prof. Luca G. Guidotti and Dr Matteo Iannacone, have observed in vivo how specific white blood cells, so-called cytotoxic T lymphocytes, identify, target and attack liver cells that are infected with the hepatitis B virus. To witness these immune cells in action in real time, the two scientists developed advanced, dynamic imaging techniques. An estimated 240 million people are chronically infected with hepatitis B worldwide.
Published: 28 July 2015
In Europe, some 463 000 women are diagnosed with breast cancer each year, making it the most common form of cancer in women. Depending on certain conditions, different drug combinations will be more - or less - effective. The EU-funded RESPONSIFY project has identified these conditions.
Published: 16 July 2015
Luckily, sarcomas are rare - but this also means that very few clinical trials have investigated better ways to tackle these malignant tumours. The fact that there are many types of sarcoma, which respond to treatment in very different ways, adds to the difficulty of organising such studies. An EU-funded cancer research project has taken up the challenge in a bid to develop targeted treatments.
Published: 14 July 2015